TNGX   $3.22  -7.20% Market Closed

Tango Therapeutics Inc
Total Cash 322.11M
totalCashPerShare 3.006
EBITDA -129.96M
Total Debt 37.84M
quickRatio 7.343
currentRatio 7.486
Total Revenue 42.51M
debtToEquity 15.277
Revenue/Share 0.406
ROA -0.21761999
ROE -0.5058
grossProfits
freeCashflow -63.78M
operatingCashflow -120.07M
earningsGrowth
revenueGrowth 0.361
grossMargins -2.18067
ebitdaMargins 0.0
operatingMargins -1.48689
profitMargins -2.74038
enterpriseValue 270.73M
forwardPE -2.219178
floatShares 50.89M
sharesOutstanding 107.14M
sharesShort 8.90M
sharesShortPriorMonth 10.45M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.89%
Short Ratio help_outline 8.71%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 2.477
Price To Book help_outline 1.31
earningsQuarterlyGrowth
netIncomeToCommon -116.49M
trailingEps -0.69%
forwardEps -1.46%
enterpriseToEbitda -2.08
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 180
lastUpdated Nov. 7, 2024, 6:55 a.m.